Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases

Stopped the clinical center has too much difficulty recruiting as a rare condition

Conditions

• Scleroderma Disease

Interventions

• DRUG: Polydeoxyribonucleotides

Sponsor

Mastelli S.r.l

Collaborators

• [object Object]